Evidence map›Paper›PMID 42110603›Full record

ArticleArchives of medical science : AMS2026

Effect of thymoquinone on cyclophosphamide-induced injury in the rat urinary bladder.

Basma Emad Aboulhoda, Shaimaa Nasr Amin, Charity Thomann, Magdy Youakim, Sherif Sabry Hassan

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Basma Emad AboulhodaAnatomy Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Shaimaa Nasr AminMedical Physiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Charity ThomannFielding Graduate University, Student-Doctor of Clinical Psychology.
Magdy YouakimAnatomy Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Sherif Sabry HassanAnatomy Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cyclophosphamide (CP) is a chemotherapeutic agent used to treat neoplastic diseases, but its side effects include hemorrhagic cystitis. Thymoquinone (TQ) is an active ingredient of Material and methods: Sixty rats were divided into 6 equal groups: untreated control (group A), TQ-treated with 10 mg/kg/day TQ for 10 days (group B1), TQ-treated with 100 mg/kg/day TQ for 5 days (group B2), toxicity control where 100 mg/kg CP was administered for 2 days (group C), CP + TQ-treated with the same TQ treatment as group B1 and 100 mg/kg CP for 2 days (group D1), and CP + TQ-treated with the same TQ treatment as group B2 and 100 mg/kg CP for 2 days (group D2). Rat urinary bladders were assessed histopathologically via hematoxylin and eosin (H&E) and Masson's trichrome stains and were evaluated for oxidative stress and cell death markers. Results: CP demonstrated significant reduction in glutathione reductase, and increased malondialdehyde levels and protein carbonylation (both Conclusions: TQ may ameliorate CP-induced oxidative injury in rat urinary bladder, via its antioxidant and antiapoptotic effects.

Indexed as

cyclophosphamide, oxidative stress, protection, urinary bladderthymoquinone

Identifiers

PMID42110603
PMCPMC13154783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.